Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Activated Natural Killer Cells Are Associated with Poor Clinical Prognosis in High-Risk B- and T- Cell Acute Lymphoblastic Leukemia

Caroline Duault, PharmD, PhD, Anil Kumar, PhD, Adeleh Taghi Khani, PhD, Sung June Lee, BA, Lu Yang, PhD, Min Huang, PhD, Christian Hurtz, PhD, Bryan Manning, BS, Lucy Ghoda, PhD, Tinisha McDonald, BS, Norman J. Lacayo, MD, Kathleen M. Sakamoto, MD PhD, Martin P. Carroll, MD, Guido Marcucci, MD, Jianhua Yu, PhD, Michael A. Caligiuri, MD, Holden T. Maecker, PhD, Srividya Swaminathan, PhD

Blood (2020) 136 (Supplement 1): 39.

https://doi.org/10.1182/blood-2020-140044

Published: 2020

Journal Articles

The ETS1 Transcription Factor Is Implicated in Human and Murine Intermediate NK Cell Development Stages

Eileen Hu, BS, Jessica Waibl-Polania, BS, Frank Frissora, MS, Larry State Beaver, Kevan Zapolnik, BS, Bethany L Mundy-Bosse, PhD, Anjali Mishra, PhD, Aharon G. Freud, MD PhD, Jianhua Yu, PhD, John C. Byrd, MD, Christopher C. Oakes, Michael Ostrowski, PhD, Natarajan Muthusamy, DVM, PhD

Blood (2018) 132 (Supplement 1): 2567.

https://doi.org/10.1182/blood-2018-99-115261

Published: 2018

Journal Articles

Combination Therapy with Daratumumab and CAR-NK Targeting CS1 for Multiple Myeloma

Yibo Zhang, PhD, Lichao Chen, Yufeng Wang, Xinxin Li, Tiffany Hughes, Hans Klingemann, Don M Benson, MD PhD, Jianhua Yu, PhD

Blood (2016) 128 (22): 1342.

https://doi.org/10.1182/blood.V128.22.1342.1342

Published: 2016

Journal Articles

Enhancement of Natural Killer Cell Interferon-Gamma Production By the Derivatives of the Natural Product Phyllanthusmins Via TLR-Mediated NF-Kb and STAT3 Signaling Pathways

Luxi Chen, Long Yi, Yuning Ren, Jianying Zhang, A. Douglas Kinghorn, Michael A. Caligiuri, MD, Jianhua Yu, PhD

Blood (2015) 126 (23): 1031.

https://doi.org/10.1182/blood.V126.23.1031.1031

Published: 2015

Journal Articles

Modulation of Natural Killer Cell Activity in the Setting of Oncolytic Virotherapy and with a Chimeric Antigen Receptor

Chen Xilin, Jianfeng Han, Chu Jianhong, Walter Meisen, Zhang Jianying, E. Antonio Chiocca, Balveen Kaur, Michael A. Caligiuri, MD, Jianhua Yu, PhD

Blood (2015) 126 (23): 210.

https://doi.org/10.1182/blood.V126.23.210.210

Published: 2015

Journal Articles

Acute Myeloid Leukemia Alters Natural Killer Cell Maturation and Functional Activation

Bethany Mundy-Bosse, PhD, McConnell Kathleen, Charlene Mao, Elshafa Ahmed, Li Chen, Steven D Scoville, Aharon G. Freud, MD PhD, Jianhua Yu, PhD, Michael A. Caligiuri, MD

Blood (2014) 124 (21): 754.

https://doi.org/10.1182/blood.V124.21.754.754

Published: 2014

Journal Articles

Remission of a Heavily Pre-Treated Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma after Treatment with Metronomic Therapy

Yuan Shunzong, MD, Haverkos Brad, Hang Su, Jianhua Yu, PhD

Blood (2014) 124 (21): 5456.

https://doi.org/10.1182/blood.V124.21.5456.5456

Published: 2014

Journal Articles

Nanoparticle-Encapsulated Allogeneic T Cells Mitigate Graft-Versus-Host Disease but Retain Graft-Versus-Leukemia Activity

Lingling Zhang, PhDMD, Shuting Zhao, Steven M. Devine, MD, Xiaoming He, PhD, Jianhua Yu, PhD

Blood (2014) 124 (21): 3820.

https://doi.org/10.1182/blood.V124.21.3820.3820

Published: 2014

Journal Articles

CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells and T Cells Enhance In Vitro and In Vivo Anti-Tumor Activity Against Human Multiple Myeloma

Jianhong Chu, PhD, Youcai Deng, Don M. Benson, Jr., MD, PhD, Shun He, Tiffany L. Hughes, Jianying Zhang, Yong Peng, Hsiaoyin Mao, Ling Yi, Kalpana Ghoshal, Xiaoming He, Steven M. Devine, MD, Xiaoliu Zhang, Michael A. Caligiuri, MD, Craig C. Hofmeister, MD, Jianhua Yu, PhD

Blood (2013) 122 (21): 14.

https://doi.org/10.1182/blood.V122.21.14.14

Published: 2013

Journal Articles

Decitabine Or 5-Azacitidine Pre-Treatment Does Not Compromise The Novel Fc-Engineered Antibody Mab 33.1-Mediated ADCC Against Primary AML Blasts - A Rationale For Combination Therapy

Shun He, PhD, Carolyn Cheney, Susan P. Whitman, PhD, Jianhua Yu, PhD, Sumithira Vasu, MBBS, William Blum, MD, Karl-Heinz Heider, PhD, Guido Marcucci, MD, Natarajan Muthusamy, DVM, Ph.D

Blood (2013) 122 (21): 3959.

https://doi.org/10.1182/blood.V122.21.3959.3959

Published: 2013

Journal Articles

FLT3L and AMD3100 Combination Increases Hematopoietic Stem Cell Mobilization and Leads To Improved Transplantation Outcome

Shun He, PhD, Deng Youcai, MS, Sumithira Vasu, MBBS, Jianhong Chu, Shunzong Yuan, Jianying Zhang, Zhijin Fan, Craig C Hofmeister, MD, Xiaoming He, Henry March, Steven M. Devine, MD, Jianhua Yu, PhD

Blood (2013) 122 (21): 901.

https://doi.org/10.1182/blood.V122.21.901.901

Published: 2013

Journal Articles

Micrornas Promote Activation and Maturation of Natural Killer Cells Through Toll-Like Receptor Signaling.

Jianhua Yu, PhD, Shun He, Lai-Chu Wu, PhD, Hsiaoyin Mao, Sumithira Vasu, MBBS, Samantha M. Jaglowski, MD, MPH, Yong Peng, Christopher Alvarez-Breckenridge, Shunzong Yuan, Ph.D., M.D., Min Wei, Jianying Zhang, Tiffany L Hughes, Kalpana Ghoshal, Steven M. Devine, MD, Michael A. Caligiuri, M.D.

Blood (2012) 120 (21): 2160.

https://doi.org/10.1182/blood.V120.21.2160.2160

Published: 2012

Journal Articles

Immune Reconstitution At Days 30 and 100 Following Allogeneic Stem Cell Transplant and Association with Subsequent Development of Chronic Graft-Versus-Host Disease

Samantha M. Jaglowski, MD, MPH, Sumithira Vasu, MBBS, Susan Geyer, PhD, Anissa Bingman, M.S., Patrick Elder, MS, Jianhua Yu, PhD, William Blum, MD, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, M.D., Craig C. Hofmeister, MD, Don M. Benson, Jr., MD, PhD, Natarajan Muthusamy, DVM, Ph.D, Steven M. Devine, MD, Leslie A Andritsos, MD, Gerard Lozanski, MD

Blood (2012) 120 (21): 1949.

https://doi.org/10.1182/blood.V120.21.1949.1949

Published: 2012

Journal Articles

Differential Distribution of Activated Innate and Adaptive Immune Subsets in G-CSF Mobilized Hematopoietic Stem Cell Allografts May Influence Incidence of Acute (aGVHD) and Chronic Graft-Versus-Host Disease (cGVHD)

Sumithira Vasu, MBBS, Samantha M. Jaglowski, MD, MPH, Susan Geyer, PhD, Anissa Bingman, M.S., Patrick Elder, M.S., Jianhua Yu, PhD, Leslie A Andritsos, MD, William Blum, MD, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, M.D., Craig C. Hofmeister, MD, Don M. Benson, Jr., MD, PhD, Natarajan Muthusamy, DVM, Ph.D, Steven M. Devine, MD, Gerard Lozanski, M.D.

Blood (2012) 120 (21): 4192.

https://doi.org/10.1182/blood.V120.21.4192.4192

Published: 2012

Journal Articles

Evidence of MicroRNA-29b and Sp1/NFκB-HDAC Regulatory Network for KIT Expression in KIT-Driven Acute Myeloid Leukemia (AML): Biologic and Therapeutic Implications.

Shujun Liu, PhD, Lai Chu Wu, PhD, Jiuxia Pang, BS, Ramasamy Santhanam, PhD, Sebastian Schwind, MD, Yue-Zhong Wu, MS, Christopher Hickey, MS, Jianhua Yu, PhD, Anjali Mishra, PhD, Heiko Becker, MD, Chenglong Li, PhD, Roger Briesewitz, PhD, Robert A. Baiocchi, MD, Kenneth K. Chan, PhD, Michael A. Caligiuri, MD, John C. Byrd, MD, Danilo Perrotti, MD, PhD, Ramiro Garzon, MD, Guido Marcucci, MD

Blood (2009) 114 (22): 938.

https://doi.org/10.1182/blood.V114.22.938.938

Published: 2009

Journal Articles

The Stage-Specific Effect of Interleukin-1 Beta (IL-1β) during Human Natural Killer Cell Development

Tiffany L Hughes, Michael Brian Becknell, M.D., Ph.D., Aharon Freud, M.D., Ph.D., Susan E Schmidt, Jianhua Yu, PhD, Charlene Mao, Mikhail Gavrilin, Ph.D., Mark Wewers, M.D., Michael A. Caligiuri, MD

Blood (2008) 112 (11): 3746.

https://doi.org/10.1182/blood.V112.11.3746.3746

Published: 2008

Journal Articles

Characterization of HDACI OSU42 as a Novel Histone Deacetylase Inhibitor in AML Cell Lines.

Jin Sun, PhD, Shujun Liu, PhD, Jianhua Yu, PhD, Min Wei, BS, Charlene Mao, PhD, Haiming Ding, PhD, Jessica Kearney, BS, LeNguyen Huynh, MS, Peter Paschka, MD, Dachun Wang, PhD, Rebecca B. Klisovic, MD, Danilo Perrotti, PhD, Ching-shih Chen, PhD, Williom George Blum, MD, Guido Marcucci, MD

Blood (2006) 108 (11): 1988.

https://doi.org/10.1182/blood.V108.11.1988.1988

Published: 2006

Journal Articles

In Vitro and In Vivo Evidence That the PP2A Inhibitor SET Regulates IFN-γ Production in Monokine-Stimulated Natural Killer Cells.

Rossana Trotta, PhD, Jessica Dal Col, PhD, Jeffrey Allard, II, BS, Paolo Neviani, PhD, Ramasamy Santhanam, PhD, Hsiaoyin Mao, MS, Brian Becknell, PhD, Jianhua Yu, PhD, Aalok Modi, BS, Bradley W. Blaser, PhD, Danilo Perrotti, MD PhD, Michael A. Caligiuri, MD

Blood (2006) 108 (11): 928.

https://doi.org/10.1182/blood.V108.11.928.928

Published: 2006

Journal Articles

In Vitro and In Vivo Evidence That TSC-22 Is a Putative Tumor Suppressor Gene in Primary Murine and Human Leukemia.

Jianhua Yu, PhD, Li Yu, PhD, Bjoern Hackanson, MD, Min Wei, BS, Zachary Boyd, BS, Akihiko Yokohama, PhD, Chunhui Liu, BS, Rossana Trotta, PhD, Hsiaoyin C. Mao, MS, Brian Becknell, PhD, Michael S. Jaung, Shujun Liu, PhD, John C. Byrd, MD, Guido Marcucci, MD, Christoph Plass, PhD, Michael A. Caligiuri, MD

Blood (2006) 108 (11): 2211.

https://doi.org/10.1182/blood.V108.11.2211.2211

Published: 2006

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Activated Natural Killer Cells Are Associated with Poor Clinical Prognosis in High-Risk B- and T- Cell Acute Lymphoblastic Leukemia

The ETS1 Transcription Factor Is Implicated in Human and Murine Intermediate NK Cell Development Stages

Combination Therapy with Daratumumab and CAR-NK Targeting CS1 for Multiple Myeloma

Enhancement of Natural Killer Cell Interferon-Gamma Production By the Derivatives of the Natural Product Phyllanthusmins Via TLR-Mediated NF-Kb and STAT3 Signaling Pathways

Modulation of Natural Killer Cell Activity in the Setting of Oncolytic Virotherapy and with a Chimeric Antigen Receptor

Acute Myeloid Leukemia Alters Natural Killer Cell Maturation and Functional Activation

Remission of a Heavily Pre-Treated Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma after Treatment with Metronomic Therapy

Nanoparticle-Encapsulated Allogeneic T Cells Mitigate Graft-Versus-Host Disease but Retain Graft-Versus-Leukemia Activity

CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells and T Cells Enhance In Vitro and In Vivo Anti-Tumor Activity Against Human Multiple Myeloma

Decitabine Or 5-Azacitidine Pre-Treatment Does Not Compromise The Novel Fc-Engineered Antibody Mab 33.1-Mediated ADCC Against Primary AML Blasts - A Rationale For Combination Therapy

FLT3L and AMD3100 Combination Increases Hematopoietic Stem Cell Mobilization and Leads To Improved Transplantation Outcome

Micrornas Promote Activation and Maturation of Natural Killer Cells Through Toll-Like Receptor Signaling.

Immune Reconstitution At Days 30 and 100 Following Allogeneic Stem Cell Transplant and Association with Subsequent Development of Chronic Graft-Versus-Host Disease

Differential Distribution of Activated Innate and Adaptive Immune Subsets in G-CSF Mobilized Hematopoietic Stem Cell Allografts May Influence Incidence of Acute (aGVHD) and Chronic Graft-Versus-Host Disease (cGVHD)

Evidence of MicroRNA-29b and Sp1/NFκB-HDAC Regulatory Network for KIT Expression in KIT-Driven Acute Myeloid Leukemia (AML): Biologic and Therapeutic Implications.

The Stage-Specific Effect of Interleukin-1 Beta (IL-1β) during Human Natural Killer Cell Development

Characterization of HDACI OSU42 as a Novel Histone Deacetylase Inhibitor in AML Cell Lines.

In Vitro and In Vivo Evidence That the PP2A Inhibitor SET Regulates IFN-γ Production in Monokine-Stimulated Natural Killer Cells.

In Vitro and In Vivo Evidence That TSC-22 Is a Putative Tumor Suppressor Gene in Primary Murine and Human Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only